Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A

Vaccine

Volumn 25, Issue 25, 2007, Pages 4795-4800

  Xiao, Chenwen ^a   Rajput, Zahid Iqbal ^a   Hu, Songhua ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Adjuvant; Foot and mouth disease; Mineral oil; Quil A; Vaccine

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN SUBCLASS; MINERAL OIL; OVALBUMIN; QUIL A; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; HEMAGGLUTINATION; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; FEMALE; FOOT-AND-MOUTH DISEASE VIRUS; HEMAGGLUTINATION TESTS; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED ICR; OVALBUMIN; SAPONINS; SWINE; VIRAL VACCINES;

EID: 34249323320     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.027     Document Type: Article

References (29)

1. Remington JP, Woods HC. The Dispensatory of the United States of America. The Southwest School of Botanical Medicine, USA; 1918.
2. Kensil C.R. Saponins as vaccine adjuvants. Crit Rev Ther Drug Carrier Syst 13 (1996) 1-56
3. Thibault P., and Richou R. Sur l'accroissement de l'immunite anti-toxique sous l'influence de l'addition de diverses substances a l'antigene (anatoxines diphterique et tetanique). C.R. Seances Soc Biol 121 (1936) 718
4. Dalsgaard K. A study of the isolation and characterization of the saponin QuilA. Evaluation of its adjuvant activity, with a special reference to the application in the vaccination of cattle against foot-and-mouth disease. Acta Vet Scand 19 (1978) 7-40
5. Wu J.Y., Gardner B.H., Murphy C.I., Seals J.R., Kensil C.R., Recchia J., et al. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J Immunol 148 5 (1992) 1519-1525
6. Soltysik S., Wu J.Y., Recchia J., Wheeler D.A., Newman M.J., Coughlin R.T., et al. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine 13 (1995) 1403-1410
7. Moignic L. Pinoy Les. vaccins en emulsion dans les corps gras ou 'lipo-vaccins'. Comptes Rendus de la Societe de Biologie 79 (1916) 201-203
8. Marti{dotless}́nez-Fernández A.R., Nogal-Ruiz J.J., López-Abán J., Ramajo V., Oleaga A., Manga-González Y., et al. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD. Vet Parasitol 126 (2004) 287-298
9. Lubroth J. Foot and mouth disease: a review for the practitioner. Vet Clin North Am Food Anim Pract 18 3 (2002) 475-499
10. Domingo E., Escarmis C., Baronowski E., Ruiz-Jarabo C.M., Carrillo E., Nunez J.I., et al. Evolution of foot and mouth disease virus. Virus 91 (2003) 47-63
11. Knowles N.J., and Samuel A.R. Molecular epidemiology of foot and mouth disease virus. Virus 91 (2003) 65-80
12. Brooksby J.B. Portraits of viruses: foot and mouth disease virus. Intervirology 18 (1982) 1-23
13. Kitching R.P. Foot-and-mouth disease. In: Aeillo S. (Ed). Merck veterinary manual. 8th ed. (1998), Merck & Co., Whitehouse Station, NJ
14. Bowersock T.L., and Martin S. Vaccine delivery to animals. Adv Drug Deliv Rev 38 (1999) 167-194
15. Gupta R.K., Rost B.E., Relyveld E., and Siber G.R. Adjuvant properties of aluminum and calcium compounds. Pharm Biotechnol 6 (1995) 229-248
16. Meloen R.H., Rowlands D.J., and Brown F. Comparison of the antibodies elicited by the individual structural polypeptides of foot and mouth disease and polio viruses. J Gen Virol 45 (1979) 761-763
17. Brown F. Antibody recognition and neutralisation of foot-and-mouth disease. Semin Viro 6 (1995) 243-248
18. McCullough K.C., Crowther J.R., Butcher R.N., Carpenter W.C., Brocchi E., Capucci L., et al. Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology 58 (1986) 421-428
19. McCullough K.C., De Simone F., Brocchi E., Capucci L., Crowther J.R., and Kihm U. Protective immune response against foot-and-mouth disease. J Virol 66 (1992) 1835-1840
20. McCullough K.C., Parkinson D., and Crowther J.R. Opsonization enhanced phagocytosis of foot-and-mouth disease virus. Immunology 65 (1988) 187-191
21. Xie Q., Li Y.G., and Zhang M.L. The detection of immune response to swine fever and FMD on a swine farm in Ningxia province. Gansu Anim Vet Sci 35 6 (2005) 8-10
22. Hao D.L., Luo R., Xu Y.F., and Li K. Analysis the antibody titer of foot and mouth disease in pigs. J Anim Sci Vet Med 24 2 (2005) 42
23. Freud J., Thomson K.J., Hough H.B., Sommer H.E., and Pisani T.M. Antibody formation and sensitization with the aid of adjuvants. J Immunol 60 (1948) 383-398
24. Gerber J D. US Patent 1989, number 4806350.
25. Oda K., Matsuda H., Murakami T., Katayama S., Ohgitani T., and Yoshikawa M. Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants. Biol Chem 381 (2000) 67-74
26. Hu S., Concha C., Lin F., and Persson W.K. Adjuvant effect of ginseng extracts on the immune responses to immunization against Staphylococcus aureus in dairy cattle. Vet Immunol Immunopathol 91 (2003) 29-37
27. Koh Y.T., Higgins S.A., Weber J.S., and Kast W.M. Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant. J Trans Med 4 (2006) 42
28. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
29. Roitt I., Brostoff J., and Male D. Immunology. 6th ed. (2001), Mosby Publications, London